innocent Drinks announces new head for UK & Ireland

innocent Drinks announces new head for UK & Ireland

Nicki Garland, head of UK&I, innocent drinks. Posted: 24 June 2025 Share this page innocent drinks, Europe’s leading healthy drinks company, announces Nicki Garland will take on the role of Head of UK & Ireland this summer. Nicki takes on the reigns from John Taylor who is set to move on to a new role…


Nicki Garland, head of UK&I, innocent drinks.

innocent drinks, Europe’s leading healthy drinks company, announces Nicki Garland will take on the role of Head of UK & Ireland this summer.

Nicki takes on the reigns from John Taylor who is set to move on to a new role as GB franchise operations senior director at Coca-Cola. John has been instrumental in shaping innocent’s journey, helping to build a brand that stands for purpose, quality, and innovation. After 17 years at innocent, the team wishes him all the best in his next chapter.

Nicki Garland has been part of innocent’s journey for over a decade. She started in the UK&I finance team, swiftly moving up to lead it before taking on strategy & planning through some of the business’s most challenging times, including Covid. She later led the European Commercial Finance team.

Before joining innocent, Nicki spent six years at Tesco, gaining a strong grounding in retail and commercial finance.

Nicki Garland, head of UK&I, said: “I’m absolutely thrilled to be stepping into the role of head of UK&I at innocent. It’s a real privilege to lead such a brilliant brand with so much heart and ambition. I’m excited to build on our strong foundations and to continue to grow to bring innocent’s mission – to make it easier to live well through the delicious goodness of fruit and veg – to life”.

Related content


Stories for you


  • B&W reserves 1GW Siemens Energy turbine capacity

    B&W reserves 1GW Siemens Energy turbine capacity

    B&W has secured twenty additional Siemens Energy steam turbine sets. The 50MW units provide 1GW of equipment capacity for accelerated data centre generation projects under the company’s FastPower programme.


  • Cambrex starts m Milan R&D expansion

    Cambrex starts $30m Milan R&D expansion

    Cambrex has started building expanded pharmaceutical R&D capacity in Milan. The $30m programme adds analytical and process-development capability, upgrades existing production plants, and provides further land for future expansion at the long-established manufacturing site.